{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:20:52Z","timestamp":1790274052903,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2015R1A2A1A10054108"],"award-info":[{"award-number":["2015R1A2A1A10054108"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2015M3A9C407581"],"award-info":[{"award-number":["2015M3A9C407581"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2014M3C1A3051476"],"award-info":[{"award-number":["2014M3C1A3051476"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2015R1A2A1A13027811"],"award-info":[{"award-number":["2015R1A2A1A13027811"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2016M3A9B5942352"],"award-info":[{"award-number":["2016M3A9B5942352"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health and Welfare","award":["HI15C0554"],"award-info":[{"award-number":["HI15C0554"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.canlet.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T14:46:51Z","timestamp":1489589211000},"page":"155-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer"],"prefix":"10.1016","volume":"396","author":[{"given":"Kyung Hee","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Kyu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kwon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Sun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.03.009_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.canlet.2017.03.009_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MOG.0000000000000096","article-title":"Recent advances in pancreatic surgery","volume":"30","author":"Bednar","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.canlet.2017.03.009_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejso.2007.07.204","article-title":"Neoadjuvant and adjuvant strategies for pancreatic cancer","volume":"34","author":"Ghaneh","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.canlet.2017.03.009_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpainsymman.2011.09.001","article-title":"Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)","volume":"43","author":"Romanus","year":"2012","journal-title":"J.\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.canlet.2017.03.009_bib6","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2006.09.2551","article-title":"Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer","volume":"25","author":"Sultana","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2017.03.009_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2013.06.003","article-title":"A\u00a0phase I clinical trial of Ad5\/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer","volume":"130","author":"Kim","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib9","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/ijc.29536","article-title":"Treatment of melanoma with a serotype 5\/3 chimeric oncolytic adenovirus coding for GM-CSF: results in\u00a0vitro, in rodents and in humans","volume":"137","author":"Bramante","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.03.009_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ijc.28696","article-title":"Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans","volume":"135","author":"Bramante","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.03.009_bib11","first-page":"5031","article-title":"The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy","volume":"60","author":"Okegawa","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.03.009_bib12","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1158\/1078-0432.CCR-05-2397","article-title":"Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses","volume":"12","author":"Reddy","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.03.009_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jgm.543","article-title":"Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells","volume":"6","author":"Nilsson","year":"2004","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.canlet.2017.03.009_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/104303401750270977","article-title":"Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved-deletion of the viral E1b-19-kD gene increases the viral oncolytic effect","volume":"12","author":"Harrison","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib15","doi-asserted-by":"crossref","first-page":"407e","DOI":"10.1097\/PRS.0b013e31825dbf56","article-title":"Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in\u00a0vitro experiments","volume":"130","author":"Lee","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.canlet.2017.03.009_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/exd.12719","article-title":"Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Dermatol"},{"key":"10.1016\/j.canlet.2017.03.009_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biomedicines2020163","article-title":"Tumor restrictions to oncolytic virus","volume":"2","author":"Koskela","year":"2014","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2017.03.009_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1042\/BJ20111240","article-title":"Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression","volume":"441","author":"Shields","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2017.03.009_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1476-4598-8-125","article-title":"Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines","volume":"8","author":"Huanwen","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.03.009_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/er.2003-0013","article-title":"Relaxin's physiological roles and other diverse actions","volume":"25","author":"Sherwood","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.canlet.2017.03.009_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm879","article-title":"Dynamic imaging of collagen and its modulation in tumors in\u00a0vivo using second-harmonic generation","volume":"9","author":"Brown","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2017.03.009_bib22","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy","volume":"98","author":"Kim","year":"2006","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.03.009_bib23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/104303403769211637","article-title":"Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner","volume":"14","author":"Kim","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gt.2013.10","article-title":"Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy","volume":"20","author":"Choi","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2011.08.066","article-title":"Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2017.03.009_bib26","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/ijc.21773","article-title":"Upregulation of mortalin\/mthsp70\/Grp75 contributes to human carcinogenesis","volume":"118","author":"Wadhwa","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.03.009_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Na","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.canlet.2017.03.009_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.cgt.7700769","article-title":"ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis","volume":"12","author":"Yun","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib29","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1182\/blood-2008-10-187237","article-title":"Toward a stem cell gene therapy for breast cancer","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.03.009_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1309\/D7AU-EYW7-4B6C-K08Y","article-title":"An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C","volume":"114","author":"O'Brien","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2017.03.009_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4251\/wjgo.v3.i11.153","article-title":"Molecular predictors of gemcitabine response in pancreatic cancer","volume":"3","author":"Voutsadakis","year":"2011","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib32","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.03.009_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2011.10439.x","article-title":"Adenovirus-relaxin gene therapy for keloids: implication for reversing pathological fibrosis","volume":"16","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.canlet.2017.03.009_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.canlet.2017.03.009_bib35","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1074\/jbc.M110.195628","article-title":"Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion","volume":"286","author":"Shields","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.03.009_bib36","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2017.03.009_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib38","doi-asserted-by":"crossref","first-page":"e0144969","DOI":"10.1371\/journal.pone.0144969","article-title":"TM4SF1 promotes gemcitabine resistance of pancreatic cancer in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.03.009_bib39","first-page":"1163","article-title":"In\u00a0vivo radiosensitizing effect of the adenovirus E1A gene in murine and human malignant tumors","volume":"15","author":"Martin-Duque","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/hum.2006.17.379","article-title":"Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin","volume":"17","author":"Yoon","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/gt.2011.141","article-title":"The oncolytic adenovirus AdDeltaDelta enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models","volume":"18","author":"Cherubini","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2017.03.009_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00708249","article-title":"Serotonin-containing EC cells in normal human gastric mucosa and in gastritis. Immunohistochemical, electron microscopic and autoradiographic studies","volume":"409","author":"Ito","year":"1986","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"10.1016\/j.canlet.2017.03.009_bib43","first-page":"250","article-title":"E1A-mediated paclitaxel sensitization in HER-2\/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.03.009_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006676-200410000-00002","article-title":"Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells","volume":"29","author":"Apte","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2017.03.009_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2010.16","article-title":"Chemotherapy: gemcitabine remains the standard of care for pancreatic cancer","volume":"7","author":"Berlin","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.03.009_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2407-13-95","article-title":"3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing","volume":"13","author":"Longati","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2017.03.009_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/med.21277","article-title":"Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein","volume":"34","author":"Cernaro","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.canlet.2017.03.009_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1444-0903.2004.00658.x","article-title":"Modern management of pancreatic carcinoma","volume":"34","author":"Goldstein","year":"2004","journal-title":"Intern. Med. J."}],"updated-by":[{"DOI":"10.1016\/j.canlet.2017.06.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:00:00Z","timestamp":1506556800000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517301738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517301738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:37:57Z","timestamp":1759592277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517301738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":48,"alternative-id":["S0304383517301738"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.03.009","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}